Biotech Aeglea BioTherapeutics Receives FDA Rare Pediatric Disease Designation for ACN00177 for the Treatment of Homocystinuria December 1, 2020
Biotech AzurRx BioPharma Announces First Patients Dosed in Turkey for Phase 2 Combination Therapy Trial of MS1819 in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency November 30, 2020
Biotech Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition November 30, 2020
Biotech Aquestive Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference November 25, 2020
Biotech Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy(TM) (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies November 25, 2020
Biotech ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference November 25, 2020